WIL Research Laboratories, LLC and WIL Research Holding Company, Inc. have announced the acquisition of Midwest BioResearch, LLC.
Together, Midwest BioResearch and WIL Research shall integrate their service offerings through scientific collaboration, sharing of best practices and marketing to provide a seamless bridge between these two highly regarded scientific organizations.
Midwest BioResearch's significant expertise in immunoanalytical and bioassay techniques and small molecule bioanalysis, supporting both clinical and nonclinical research, and their expertise in genetic toxicology, complements WIL Research's contract research service offerings that include expertise in chronic, neuro-, inhalation, and intravenous toxicology, developmental and reproductive toxicology, safety pharmacology, bioanalytical chemistry and metabolism.
This acquisition ensures the continuity of management, quality science and service to our clients. Michael Schlosser, PhD, DABT, president and founder of Midwest BioResearch, will continue to lead the existing Skokie, Illinois site reporting to Christopher P. Chengelis, PhD, DABT, vice president and chief scientific officer at WIL Research.
Dr. Schlosser has more than 20 years of experience within the pharmaceutical industry and 25 years of experience in toxicology. "Midwest BioResearch rounds out our service offerings, particularly in the areas of genetic toxicity and biotech and clinical support capabilities," said Dr. Chengelis. "We also benefit from a world-class staff with significant pharmaceutical and biotechnology industry experience and the addition of a program services consulting group."
In addition, Sal Guccione, chief executive officer at WIL Research Holding Company, Inc. stated "that this transaction greatly enhances our capabilities to serve our clients in small and large molecule drug development. We are delighted to welcome this experienced team to the WIL family of research companies."
Midwest BioResearch, LLC was founded in 2003 by scientists, directors and managers from major pharmaceutical companies to provide drug disposition and toxicology services.
WIL Research Laboratories, LLC is a contract research organization that provides an interdisciplinary approach to non-clinical toxicology, pharmacology, metabolism and both clinical and non-clinical bioanalytical services.